chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: Abdominal pain; Sweats; Chills; A fever of >100; Headache; Fatigue/tiredness; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal pain), HYPERHIDROSIS (Sweats), CHILLS (Chills), PYREXIA (A fever of >100) and HEADACHE (Headache) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain), HYPERHIDROSIS (Sweats), CHILLS (Chills), PYREXIA (A fever of >100), HEADACHE (Headache), FATIGUE (Fatigue/tiredness) and MYALGIA (Muscle aches). At the time of the report, ABDOMINAL PAIN (Abdominal pain), HYPERHIDROSIS (Sweats), CHILLS (Chills), PYREXIA (A fever of >100), HEADACHE (Headache), FATIGUE (Fatigue/tiredness) and MYALGIA (Muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: >100 (High) a fever of >100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (sore arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) and PAIN IN EXTREMITY (Sore arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 19-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, SARS-CoV-2 test: positive (Positive) Tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus
Clinical narrative: her ear was itchy all over, her face was itchy all over, itchy all over again; her body was red,a little red in the face, a little red in the ears; her ear hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (her ear was itchy all over, her face was itchy all over, itchy all over again), ERYTHEMA (her body was red,a little red in the face, a little red in the ears) and FEELING HOT (her ear hot to touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced FEELING HOT (her ear hot to touch). On an unknown date, the patient experienced PRURITUS (her ear was itchy all over, her face was itchy all over, itchy all over again) and ERYTHEMA (her body was red,a little red in the face, a little red in the ears). At the time of the report, PRURITUS (her ear was itchy all over, her face was itchy all over, itchy all over again), ERYTHEMA (her body was red,a little red in the face, a little red in the ears) and FEELING HOT (her ear hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 21 Feb 2021, after administration of vaccine, the patient experienced itchy all over, itchy all over the body, a little red in the face and ears, ear hot to touch, her ear and her face was itchy.  Concomitant medications were not provided. Treatment medication included 2 diphenhydramine.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy rash around the injection site; Itchy rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy rash around the injection site) and VACCINATION SITE RASH (Itchy rash around the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy rash around the injection site) and VACCINATION SITE RASH (Itchy rash around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy rash around the injection site) and VACCINATION SITE RASH (Itchy rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate, Pain in extremity, Palpitations
Clinical narrative: palpitation; Pain in legs; Arm soreness; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitation), PAIN IN EXTREMITY (Pain in legs), PAIN IN EXTREMITY (Arm soreness) and FATIGUE (fatigue) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (palpitation), PAIN IN EXTREMITY (Pain in legs), PAIN IN EXTREMITY (Arm soreness) and FATIGUE (fatigue). At the time of the report, PALPITATIONS (palpitation), PAIN IN EXTREMITY (Pain in legs), PAIN IN EXTREMITY (Arm soreness) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Heart rate: 130 (High) Initially 130 and then dropped to 105.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Decreased appetite, Feeling abnormal, Malaise
Clinical narrative: started feeling sick; Coughing; Feel bad; not very good appetite; Fever/fever of 102°F and fluctuated to 100°F.; Feels kinda weak; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started feeling sick), COUGH (Coughing), FEELING ABNORMAL (Feel bad), DECREASED APPETITE (not very good appetite) and PYREXIA (Fever/fever of 102°F and fluctuated to 100°F.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN, METFORMIN HYDROCHLORIDE, AMLODIPINE (AMLOPIN [AMLODIPINE]), METOPROLOL and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MALAISE (started feeling sick), COUGH (Coughing), FEELING ABNORMAL (Feel bad), DECREASED APPETITE (not very good appetite), PYREXIA (Fever/fever of 102°F and fluctuated to 100°F.) and ASTHENIA (Feels kinda weak). At the time of the report, MALAISE (started feeling sick), COUGH (Coughing), FEELING ABNORMAL (Feel bad), DECREASED APPETITE (not very good appetite), PYREXIA (Fever/fever of 102°F and fluctuated to 100°F.) and ASTHENIA (Feels kinda weak) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included mutinex DM dextromthorphan 16 mg, guaifenesin 1200 mg 2/day, acetaminophen and ibuprofen. the patient SARS-CoV-2 test report came back positive on 19-Feb-2021.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: started feeling sick; Coughing; Feel bad; not very good appetite; Fever/fever of 102°F and fluctuated to 100°F.; Feels kinda weak; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started feeling sick), COUGH (Coughing), FEELING ABNORMAL (Feel bad), DECREASED APPETITE (not very good appetite) and PYREXIA (Fever/fever of 102°F and fluctuated to 100°F.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN, METFORMIN HYDROCHLORIDE, AMLODIPINE (AMLOPIN [AMLODIPINE]), METOPROLOL and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MALAISE (started feeling sick), COUGH (Coughing), FEELING ABNORMAL (Feel bad), DECREASED APPETITE (not very good appetite), PYREXIA (Fever/fever of 102°F and fluctuated to 100°F.) and ASTHENIA (Feels kinda weak). At the time of the report, MALAISE (started feeling sick), COUGH (Coughing), FEELING ABNORMAL (Feel bad), DECREASED APPETITE (not very good appetite), PYREXIA (Fever/fever of 102°F and fluctuated to 100°F.) and ASTHENIA (Feels kinda weak) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included mutinex DM dextromthorphan 16 mg, guaifenesin 1200 mg 2/day, acetaminophen and ibuprofen. the patient SARS-CoV-2 test report came back positive on 19-Feb-2021.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Diagnosed with COVID; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Diagnosed with COVID) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID). At the time of the report, COVID-19 (Diagnosed with COVID) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, SARS-CoV-2 test: positive (Positive) diagnosed with COVID..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No information regarding corrective treatment was reported by the patient.     This case was linked to MOD-2021-249750 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow-up information received contains significant information as outcome updated to recovered. Second dose case was added in additional information.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Malaise, Pyrexia
Clinical narrative: Feels weak with no energy; Chills; Fever; Did not feel well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel well), ASTHENIA (Feels weak with no energy), CHILLS (Chills) and PYREXIA (Fever) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Localised infection. Concurrent medical conditions included Diabetes, Cholesterol, Depression and Heart rate. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), METFORMIN, GABAPENTIN, BENZONATATE and VITAMIN B12 NOS for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced MALAISE (Did not feel well), CHILLS (Chills) and PYREXIA (Fever). On 24-Feb-2021, the patient experienced ASTHENIA (Feels weak with no energy). On 24-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, MALAISE (Did not feel well) and ASTHENIA (Feels weak with no energy) outcome was unknown and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included glucose pills, cholesterol medications, blood thinner, heart rate pills, depression medication and antibiotics for toe infection. Treatment medications included acetaminophen and ice bath.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash
Clinical narrative: Itchy splotches on upper part of face; Hurt if touched; Multiple itchy, touch sensitive dark spots on face size of a nickel; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy splotches on upper part of face), PAIN (Hurt if touched) and RASH (Multiple itchy, touch sensitive dark spots on face size of a nickel) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: ZOSTER (The patient received first dose shingles vaccine.) on 03-Jan-2021. Concurrent medical conditions included Hypertension and Seasonal allergy.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PRURITUS (Itchy splotches on upper part of face), PAIN (Hurt if touched) and RASH (Multiple itchy, touch sensitive dark spots on face size of a nickel). At the time of the report, PRURITUS (Itchy splotches on upper part of face), PAIN (Hurt if touched) and RASH (Multiple itchy, touch sensitive dark spots on face size of a nickel) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list include high blood pressure medication and inhaler for seasonal allergies. Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Vaccination site rash
Clinical narrative: Rash around injection site; Chills; headache; Body ache; fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Body ache), FATIGUE (fatigue), VACCINATION SITE RASH (Rash around injection site), CHILLS (Chills) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No specified medical history has been reported.     On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (Body ache), FATIGUE (fatigue), CHILLS (Chills) and HEADACHE (headache). On an unknown date, the patient experienced VACCINATION SITE RASH (Rash around injection site). On 25-Jan-2021, PAIN (Body ache), CHILLS (Chills) and HEADACHE (headache) had resolved. At the time of the report, FATIGUE (fatigue) and VACCINATION SITE RASH (Rash around injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant and treatment medications were reported.   This case was linked to MOD-2021-023601 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: TCR received on 14 Jul 2021 contain adverse events ,patient detail information
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: feeling nauseous; A spontaneous report (United states) was received from a consumer concerning, a female patient of an unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and felt nauseous/nausea.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On an unknown date, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, post receiving the vaccine the patient felt nauseous for 3 days.  Treatment information was unknown.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) was not applicable.  The outcome of the event, felt nauseous was considered resolved at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: sore right arm that lasted one week; A spontaneous report (United States) was received from a consumer concerning a 76 Year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced limb discomfort.  The patient's medical history was provided as COVID-19,high blood pressure and high cholesterol.  The patient was also taking  concomitant medications like vitamins,unknown medication for high blood pressure and high cholesterol.  On 13 Feb 2021, prior to the onset of the events, the patient received their first dose ,0.5ml of  planned doses of mRNA-1273 (lot/batch: 024M20A) intramuscularlly on her right arm for prophylaxis of COVID-19 infection.   On the same day,patient experienced a sore right arm. It was lasted for one week .  The patient also reported that her second dose of vaccine is scheduled to 13 Mar 2021.    The outcome of the event was reported as resolved on 20 Feb 2021.  No treatment information was provided .  Action taken with mRNA-1273 in response to the events was not reported.; Sender's Comments:  MOD-2021-023555:same reporter, different patient
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Vomiting
Clinical narrative: Dizziness; Headache; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 24-Feb-2021, the patient experienced DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (Vomiting).   At the time of the report, DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (Vomiting) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: redness on the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness on the arm of injection) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 120L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included ESCITALOPRAM for Anxiety, METOPROLOL, DIGOXIN and LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for an unknown indication.  On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 17-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness on the arm of injection). The patient was treated with BETAMETHASONE (topical) for Adverse event, at a dose of 0.5 percent.   At the time of the report, VACCINATION SITE ERYTHEMA (redness on the arm of injection) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-023617 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Cough, Dyspnoea, Eating disorder symptom
Clinical narrative: cough; can't eat; difficulty breathing; feeling weak; headache; extreme pain on back of neck; extreme pain on arm; could not sleep; extreme pain on shoulder; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (extreme pain on back of neck), VACCINATION SITE PAIN (extreme pain on arm), INSOMNIA (could not sleep), COUGH (cough) and EATING DISORDER SYMPTOM (can't eat) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Hypertension and Cholesterol.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 19-Feb-2021, the patient experienced NECK PAIN (extreme pain on back of neck), VACCINATION SITE PAIN (extreme pain on arm), INSOMNIA (could not sleep) and ARTHRALGIA (extreme pain on shoulder).   On 20-Feb-2021, the patient experienced EATING DISORDER SYMPTOM (can't eat), DYSPNOEA (difficulty breathing), ASTHENIA (feeling weak) and HEADACHE (headache).   On an unknown date, the patient experienced COUGH (cough). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Pain, at an unspecified dose and frequency.   At the time of the report, NECK PAIN (extreme pain on back of neck), VACCINATION SITE PAIN (extreme pain on arm), INSOMNIA (could not sleep) and ARTHRALGIA (extreme pain on shoulder) had resolved and COUGH (cough), EATING DISORDER SYMPTOM (can't eat), DYSPNOEA (difficulty breathing), ASTHENIA (feeling weak) and HEADACHE (headache) had not resolved.      Patient's treatment medications included high blood pressure and cholesterol medications.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Neck pain, Vaccination site pain
Clinical narrative: cough; can't eat; difficulty breathing; feeling weak; headache; extreme pain on back of neck; extreme pain on arm; could not sleep; extreme pain on shoulder; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (extreme pain on back of neck), VACCINATION SITE PAIN (extreme pain on arm), INSOMNIA (could not sleep), COUGH (cough) and EATING DISORDER SYMPTOM (can't eat) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Hypertension and Cholesterol.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 19-Feb-2021, the patient experienced NECK PAIN (extreme pain on back of neck), VACCINATION SITE PAIN (extreme pain on arm), INSOMNIA (could not sleep) and ARTHRALGIA (extreme pain on shoulder).   On 20-Feb-2021, the patient experienced EATING DISORDER SYMPTOM (can't eat), DYSPNOEA (difficulty breathing), ASTHENIA (feeling weak) and HEADACHE (headache).   On an unknown date, the patient experienced COUGH (cough). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Pain, at an unspecified dose and frequency.   At the time of the report, NECK PAIN (extreme pain on back of neck), VACCINATION SITE PAIN (extreme pain on arm), INSOMNIA (could not sleep) and ARTHRALGIA (extreme pain on shoulder) had resolved and COUGH (cough), EATING DISORDER SYMPTOM (can't eat), DYSPNOEA (difficulty breathing), ASTHENIA (feeling weak) and HEADACHE (headache) had not resolved.      Patient's treatment medications included high blood pressure and cholesterol medications.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in upper right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in upper right arm) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL for Hypertension, NAPROXEN SODIUM (ALEVE) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in upper right arm). At the time of the report, PAIN IN EXTREMITY (Soreness in upper right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.    Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Suspected COVID-19, Tendonitis
Clinical narrative: mild covid symptoms; unbearable pain; tendonitis; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN (unbearable pain), TENDONITIS (tendonitis) and SUSPECTED COVID-19 (mild covid symptoms) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 28-Jan-2021, the patient experienced PAIN (unbearable pain) and TENDONITIS (tendonitis). On an unknown date, the patient experienced SUSPECTED COVID-19 (mild covid symptoms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (unbearable pain), TENDONITIS (tendonitis) and SUSPECTED COVID-19 (mild covid symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity
Clinical narrative: Headache; Very sore arm; Achiness; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very sore arm), PAIN (Achiness), CHILLS (Chills) and HEADACHE (Headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included LEVOTHYROXINE and ATORVASTATIN for an unknown indication, AMLODIPINE.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (Very sore arm), PAIN (Achiness) and CHILLS (Chills). On 23-Feb-2021, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Very sore arm), PAIN (Achiness), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            Treatment included Tylenol was reported.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Oral candidiasis
Clinical narrative: Thrush on tongue; This spontaneous case was reported by a consumer and describes the occurrence of ORAL CANDIDIASIS (Thrush on tongue) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ORAL CANDIDIASIS (Thrush on tongue). At the time of the report, ORAL CANDIDIASIS (Thrush on tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant medication was not provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Injection site swelling, Pain in extremity
Clinical narrative: pain like beesting at time of injection; redness; Sore arm; Swelling on injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE PAIN (pain like beesting at time of injection), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (redness) and INJECTION SITE SWELLING (Swelling on injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B20A and 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced INJECTION SITE PAIN (pain like beesting at time of injection). an unknown date, the patient experienced ERYTHEMA (redness) and INJECTION SITE SWELLING (Swelling on injection site). The patient was treated with IBUPROFEN at a dose of unkown. At the time of the report, INJECTION SITE PAIN (pain like beesting at time of injection), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (redness) and INJECTION SITE SWELLING (Swelling on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment includes cold compress and then reaction subsided.   Reporter did not allow further contact
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: nausea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills). At the time of the report, NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            Treatment information was not provided.  Concomitant medication was not provided.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: pink area at injection site; injection site hot; injection site achy; more sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (pink area at injection site), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE PAIN (injection site achy) and HYPERSOMNIA (more sleep) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (pink area at injection site), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE PAIN (injection site achy) and HYPERSOMNIA (more sleep). At the time of the report, VACCINATION SITE ERYTHEMA (pink area at injection site), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE PAIN (injection site achy) and HYPERSOMNIA (more sleep) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Oropharyngeal pain, Pruritus, Pyrexia, Rash
Clinical narrative: Flat, red, itching, burning rash all over her body; Flat, red, itching, burning rash all over her body; Flat, red, itching, burning rash all over her body; Sore throat; Low-grade fever; Drowsiness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Flat, red, itching, burning rash all over her body), PRURITUS (Flat, red, itching, burning rash all over her body), RASH (Flat, red, itching, burning rash all over her body), OROPHARYNGEAL PAIN (Sore throat) and PYREXIA (Low-grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event reported.).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced ERYTHEMA (Flat, red, itching, burning rash all over her body), PRURITUS (Flat, red, itching, burning rash all over her body), RASH (Flat, red, itching, burning rash all over her body), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Low-grade fever) and SOMNOLENCE (Drowsiness). On 18-Feb-2021, ERYTHEMA (Flat, red, itching, burning rash all over her body), PRURITUS (Flat, red, itching, burning rash all over her body), RASH (Flat, red, itching, burning rash all over her body), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Low-grade fever) and SOMNOLENCE (Drowsiness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Flat, red, itching, burning rash all over her body; Flat, red, itching, burning rash all over her body; Flat, red, itching, burning rash all over her body; Sore throat; Low-grade fever; Drowsiness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Flat, red, itching, burning rash all over her body), PRURITUS (Flat, red, itching, burning rash all over her body), RASH (Flat, red, itching, burning rash all over her body), OROPHARYNGEAL PAIN (Sore throat) and PYREXIA (Low-grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event reported.).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced ERYTHEMA (Flat, red, itching, burning rash all over her body), PRURITUS (Flat, red, itching, burning rash all over her body), RASH (Flat, red, itching, burning rash all over her body), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Low-grade fever) and SOMNOLENCE (Drowsiness). On 18-Feb-2021, ERYTHEMA (Flat, red, itching, burning rash all over her body), PRURITUS (Flat, red, itching, burning rash all over her body), RASH (Flat, red, itching, burning rash all over her body), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Low-grade fever) and SOMNOLENCE (Drowsiness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Warmth at the injection site; redness; rash; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warmth at the injection site), INJECTION SITE ERYTHEMA (redness) and INJECTION SITE RASH (rash) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warmth at the injection site), INJECTION SITE ERYTHEMA (redness) and INJECTION SITE RASH (rash). At the time of the report, INJECTION SITE WARMTH (Warmth at the injection site), INJECTION SITE ERYTHEMA (redness) and INJECTION SITE RASH (rash) outcome was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: a red rash that itches; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (a red rash that itches) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included ATENOLOL, PRAVASTATIN, DEXAMETHASONE (MAXIDEX OPHTHALMIC [DEXAMETHASONE]), LORAZEPAM (ATIVAN), CHLORMEZANONE (RESTORIL [CHLORMEZANONE]), AMLODIPINE BESILATE (NORVASC), IBUPROFEN and GABAPENTIN for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced RASH PRURITIC (a red rash that itches). At the time of the report, RASH PRURITIC (a red rash that itches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications like Alcohol to stop itching, Benadryl capsule and Benadryl cream were included.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up received on 25-MAY-2021 and contains no new information
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore left arm that lasted less than a week; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm that lasted less than a week) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (July 2020). Concurrent medical conditions included Hypertension and Joint pain (the patient is having joint aches as reported in current medical condition.).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore left arm that lasted less than a week). At the time of the report, PAIN IN EXTREMITY (sore left arm that lasted less than a week) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include unknown "hypertension" medication to treat high blood pressure was reported. No treatment information was reported.   This case was linked to MOD-2021-023397 (E2B Linked Report).; Sender's Comments:  MOD-2021-023397:same reporter, different patient
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia, Vomiting
Clinical narrative: fever; fatigue; vomiting; chills; body ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), FATIGUE (fatigue), VOMITING (vomiting), CHILLS (chills) and PAIN (body ache) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L2OA) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), FATIGUE (fatigue), VOMITING (vomiting), CHILLS (chills) and PAIN (body ache). At the time of the report, PYREXIA (fever), FATIGUE (fatigue), VOMITING (vomiting), CHILLS (chills) and PAIN (body ache) outcome was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pyrexia
Clinical narrative: Fever; Could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and INSOMNIA (Could not sleep) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PYREXIA (Fever) and INSOMNIA (Could not sleep). At the time of the report, PYREXIA (Fever) and INSOMNIA (Could not sleep) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: mild pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (mild pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (mild pain). At the time of the report, PAIN (mild pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness, Fatigue, Nausea
Clinical narrative: Its almost dizziness; Feels weak; Soreness where the shot went (left arm); Had episodes of nausea; Very, very tired; Mild diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Mild diarrhea), DIZZINESS (Its almost dizziness), ASTHENIA (Feels weak), VACCINATION SITE PAIN (Soreness where the shot went (left arm)) and NAUSEA (Had episodes of nausea) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced DIARRHOEA (Mild diarrhea). 21-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness where the shot went (left arm)), NAUSEA (Had episodes of nausea) and FATIGUE (Very, very tired). On 23-Feb-2021, the patient experienced ASTHENIA (Feels weak). On an unknown date, the patient experienced DIZZINESS (Its almost dizziness). On 26-Feb-2021, DIARRHOEA (Mild diarrhea), DIZZINESS (Its almost dizziness), ASTHENIA (Feels weak), VACCINATION SITE PAIN (Soreness where the shot went (left arm)), NAUSEA (Had episodes of nausea) and FATIGUE (Very, very tired) had resolved.            This case was linked to MOD-2021-023222 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: New event added. The outcome of the events changed from unknown to recovered.